High-sensitivity C-reactive protein methods examined.

Because C-reactive protein (CRP) has prognostic value in patients with acute coronary syndromes and in apparently healthy people (1), various high-sensitivity CRP (hs-CRP) methods have been introduced (2)(3). For the clinical laboratory, it is of course most practical if one CRP method can be used for the complete measuring range (0.2–1000 mg/L) to report reliable CRP results regardless of the clinical context. We report here the evaluation of a hs-CRP method for the Beckman Coulter IMMAGE®, which is compared with the IMMULITE and BNA hs-CRP methods, as well as with the Beckman Synchron LX®20 CRP method for the higher range. Venous blood samples were collected from 291 ostensibly healthy blood donors, 177 males and 114 females presenting at the Sanguin Blood Bank in Maastricht. Samples for method comparison were collected from 531 patients for whom a CRP was requested for routine analysis. The Medical Ethical Committee of the Hospital approved the procedure followed. Serum was separated from the red cells by centrifugation at 2500 g for 20 min and stored at −70 °C until analysis (4). The hs-CRP detection method on the IMMULITE automated analyzer (Diagnostic Product Corporation) is a two-site chemiluminescent enzyme immunometric assay with a detection limit of 0.10 mg/L and a measuring range of 0.10–500 mg/L. hs-CRP analysis is performed on the BNA nephelometer (Dade Behring) by particle-enhanced immunonephelometry with a detection limit of 0.18 mg/L and a measuring range of 0.18–1150 mg/L. The IMMAGE hs-CRP (trade name, IMMAGE CRPH; Beckman Coulter) is a turbidimetric method based on the peak rate principle (2) measured by a near-infrared particle immunoassay, with a laser diode at 940 nm, a detection limit of 0.20 mg/L, and a measuring range of 0.20–1440 mg/L. To improve sensitivity, the latex particle size is now increased three- …

[1]  G. Lowe,et al.  Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.

[2]  C. Burtis Tietz textbook of Clinical Chemistry , 1994 .

[3]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[4]  N. Rifai,et al.  Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. , 2000, Clinical chemistry.

[5]  R F Martin,et al.  General deming regression for estimating systematic bias and its confidence interval in method-comparison studies. , 2000, Clinical chemistry.

[6]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[7]  N Rifai,et al.  Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. , 2001, Clinical chemistry.

[8]  J Dausset,et al.  Letter: Histocompatibility determinants in multiple sclerosis. , 1974, Lancet.

[9]  P. Ridker,et al.  Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. , 2001, Clinical chemistry.

[10]  N Rifai,et al.  High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. , 2001, Clinical chemistry.